buprenorphine
Ligand Summary
A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use.
UNII: 40D3SCR4GZ
PubChem: 9848990
PubChem: 644073
Guide to Pharmacology: 1670
ChEMBL: CHEMBL511142
ChEMBL: CHEMBL560511
DrugCentral: 434
LyCHI: 1MYL2TZ39DL2
Target Activities
OPRM1
Mu-type opioid receptor
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
- | 8.8 | |||||
Ki | 8.29 | PARTIAL AGONIST | ||||
OPRK1
Kappa-type opioid receptor
2 Activities
Items per page:
1 – 2 of 2
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | 10.4 | Eur J Med Chem, (2017) 141:None:632 | ||||
Ki | 9.01 | ANTAGONIST | ||||
OPRL1
Nociceptin receptor
1 Activities
Items per page:
1 – 1 of 1
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | 7.11 | |||||